CELG.RT
Morgan Stanley’s Bristol-Myers Squibb Company Contingent Value Rights CELG.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3 | Hold |
119
| – | – | ﹤0.01% | 8061 |
|
|
2025
Q1 | $6 | Hold |
119
| – | – | ﹤0.01% | 8023 |
|
|
2024
Q4 | $6 | Hold |
119
| – | – | ﹤0.01% | 7922 |
|
|
2024
Q3 | $6 | Sell |
119
-45
| -27% | -$2 | ﹤0.01% | 7881 |
|
|
2024
Q2 | $7 | Hold |
164
| – | – | ﹤0.01% | 7794 |
|
|
2024
Q1 | $9 | Sell |
164
-164
| -50% | -$9 | ﹤0.01% | 7772 |
|
|
2023
Q4 | $30 | Buy |
328
+164
| +100% | +$15 | ﹤0.01% | 7733 |
|
|
2023
Q3 | $16 | Hold |
164
| – | – | ﹤0.01% | 7546 |
|
|
2023
Q2 | $18 | Hold |
164
| – | – | ﹤0.01% | 7587 |
|
|
2023
Q1 | $20 | Hold |
164
| – | – | ﹤0.01% | 7639 |
|
|
2022
Q4 | $19 | Hold |
164
| – | – | ﹤0.01% | 7774 |
|
|
2022
Q3 | $0 | Buy |
164
+59
| +56% | – | ﹤0.01% | 7717 |
|
|
2022
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 7823 |
|
|
2022
Q1 | $0 | Hold |
105
| – | – | ﹤0.01% | 7973 |
|
|
2021
Q4 | $0 | Hold |
105
| – | – | ﹤0.01% | 7987 |
|
|
2021
Q3 | $0 | Hold |
105
| – | – | ﹤0.01% | 7938 |
|
|
2021
Q2 | $0 | Hold |
105
| – | – | ﹤0.01% | 7747 |
|
|
2021
Q1 | $0 | Buy |
105
+66
| +169% | – | ﹤0.01% | 7486 |
|
|
2020
Q4 | $0 | Sell |
39
-5
| -11% | – | ﹤0.01% | 7041 |
|
|
2020
Q3 | $0 | Hold |
44
| – | – | ﹤0.01% | 6737 |
|
|
2020
Q2 | $0 | Hold |
44
| – | – | ﹤0.01% | 6609 |
|
|
2020
Q1 | $0 | Sell |
44
-1,125
| -96% | – | ﹤0.01% | 6574 |
|
|
2019
Q4 | $1K | Buy |
+1,169
| New | +$1K | ﹤0.01% | 6555 |
|